160 related articles for article (PubMed ID: 15475442)
1. The spermatozoa protein, SLLP1, is a novel cancer-testis antigen in hematologic malignancies.
Wang Z; Zhang Y; Mandal A; Zhang J; Giles FJ; Herr JC; Lim SH
Clin Cancer Res; 2004 Oct; 10(19):6544-50. PubMed ID: 15475442
[TBL] [Abstract][Full Text] [Related]
2. SLLP1, a unique, intra-acrosomal, non-bacteriolytic, c lysozyme-like protein of human spermatozoa.
Mandal A; Klotz KL; Shetty J; Jayes FL; Wolkowicz MJ; Bolling LC; Coonrod SA; Black MB; Diekman AB; Haystead TA; Flickinger CJ; Herr JC
Biol Reprod; 2003 May; 68(5):1525-37. PubMed ID: 12606493
[TBL] [Abstract][Full Text] [Related]
3. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
4. CABYR is a novel cancer-testis antigen in lung cancer.
Luo C; Xiao X; Liu D; Chen S; Li M; Xu A; Liu J; Gao S; Wu S; He D
Clin Cancer Res; 2007 Feb; 13(4):1288-97. PubMed ID: 17317841
[TBL] [Abstract][Full Text] [Related]
5. A yeast two-hybrid system using Sp17 identified Ropporin as a novel cancer-testis antigen in hematologic malignancies.
Li Z; Li W; Meklat F; Wang Z; Zhang J; Zhang Y; Lim SH
Int J Cancer; 2007 Oct; 121(7):1507-11. PubMed ID: 17551920
[TBL] [Abstract][Full Text] [Related]
6. Mouse SLLP1, a sperm lysozyme-like protein involved in sperm-egg binding and fertilization.
Herrero MB; Mandal A; Digilio LC; Coonrod SA; Maier B; Herr JC
Dev Biol; 2005 Aug; 284(1):126-42. PubMed ID: 15982649
[TBL] [Abstract][Full Text] [Related]
7. SEMG-1 expression in early stage chronic lymphocytic leukemia.
Ahmed SU; Meklat F; Shahriar M; Zhang J; Mastulov S; Giannakouros T; Jewell A; Zhang Y; Lim SH
Cytotherapy; 2009; 11(2):238-44. PubMed ID: 19241194
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
[TBL] [Abstract][Full Text] [Related]
9. Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies.
Wang Z; Zhang Y; Liu H; Salati E; Chiriva-Internati M; Lim SH
Blood; 2003 Feb; 101(3):955-60. PubMed ID: 12393489
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel prostate cancer-associated tumor antigen.
Miles AK; Rogers A; Li G; Seth R; Powe D; McArdle SE; McCulloch TA; Bishop MC; Rees RC
Prostate; 2007 Feb; 67(3):274-87. PubMed ID: 17192878
[TBL] [Abstract][Full Text] [Related]
11. Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma.
Yousef S; Heise J; Lajmi N; Bartels K; Kröger N; Luetkens T; Atanackovic D
J Transl Med; 2015 Jun; 13():197. PubMed ID: 26088750
[TBL] [Abstract][Full Text] [Related]
12. Expression of testicular genes in haematological malignancies.
Lim SH; Austin S; Owen-Jones E; Robinson L
Br J Cancer; 1999 Dec; 81(7):1162-4. PubMed ID: 10584877
[TBL] [Abstract][Full Text] [Related]
13. NY-ESO-1 expression and immunogenicity in esophageal cancer.
Fujita S; Wada H; Jungbluth AA; Sato S; Nakata T; Noguchi Y; Doki Y; Yasui M; Sugita Y; Yasuda T; Yano M; Ono T; Chen YT; Higashiyama M; Gnjatic S; Old LJ; Nakayama E; Monden M
Clin Cancer Res; 2004 Oct; 10(19):6551-8. PubMed ID: 15475443
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel cancer-testis antigen CRT2 frequently expressed in various cancers using representational differential analysis.
Hayashi E; Matsuzaki Y; Hasegawa G; Yaguchi T; Kurihara S; Fujita T; Kageshita T; Sano M; Kawakami Y
Clin Cancer Res; 2007 Nov; 13(21):6267-74. PubMed ID: 17975137
[TBL] [Abstract][Full Text] [Related]
15. ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer.
John T; Caballero OL; Svobodová SJ; Kong A; Chua R; Browning J; Fortunato S; Deb S; Hsu M; Gedye CA; Davis ID; Altorki N; Simpson AJ; Chen YT; Monk M; Cebon JS
Clin Cancer Res; 2008 Jun; 14(11):3291-8. PubMed ID: 18519755
[TBL] [Abstract][Full Text] [Related]
16. Combined real time PCR and immunohistochemical evaluation of sperm protein 17 as a cancer-testis antigen.
Zhang Y; Wang Z; Robinson WR; Lim SH
Eur J Haematol; 2004 Oct; 73(4):280-4. PubMed ID: 15347315
[TBL] [Abstract][Full Text] [Related]
17. XAGE-1 expression in non-small cell lung cancer and antibody response in patients.
Nakagawa K; Noguchi Y; Uenaka A; Sato S; Okumura H; Tanaka M; Shimono M; Ali Eldib AM; Ono T; Ohara N; Yoshino T; Yamashita K; Tsunoda T; Aoe M; Shimizu N; Nakayama E
Clin Cancer Res; 2005 Aug; 11(15):5496-503. PubMed ID: 16061866
[TBL] [Abstract][Full Text] [Related]
18. Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients.
Gagnon A; Kim JH; Schorge JO; Ye B; Liu B; Hasselblatt K; Welch WR; Bandera CA; Mok SC
Clin Cancer Res; 2008 Feb; 14(3):764-71. PubMed ID: 18245537
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen.
Dubovsky JA; McNeel DG; Powers JJ; Gordon J; Sotomayor EM; Pinilla-Ibarz JA
Clin Cancer Res; 2009 May; 15(10):3406-15. PubMed ID: 19401350
[TBL] [Abstract][Full Text] [Related]
20. The specific immune response to tumor antigen CP1 and its correlation with improved survival in colon cancer patients.
Liu FF; Dong XY; Pang XW; Xing Q; Wang HC; Zhang HG; Li Y; Yin YH; Fant M; Ye YJ; Shen DH; Zhang Y; Wang S; Chen WF
Gastroenterology; 2008 Apr; 134(4):998-1006. PubMed ID: 18395081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
